Advertisement
Product › Details
injectional drug delivery technology
Next higher product group | drug delivery technology (drug formulation technology) | |
Record changed: 2024-04-18 |
Advertisement
More documents for injectional drug delivery technology
- [1] MedinCell S.A.. (4/16/24). "Press Release: Medincell Enters into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies". Montpellier....
- [2] Eli Lilly and Company. (11/17/23). "Press Release: Lilly to Expand Injectable Manufacturing Capacity with Planned $2.5 Billion Site in Germany". Indianapolis, IN....
- [3] Sensorion S.A.. (1/31/23). "Press Release: Sensorion and Eveon Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments into the Inner Ear". Montpellier....
- [4] Sanofi S.A.. (3/15/22). "Press Release: Sanofi Announces €300 Million Collaboration with Blackstone Life Sciences to Advance an Innovative Treatment for Multiple Myeloma". Paris....
- [5] Becton, Dickinson and Company. (5/18/21). "Press Release: BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain to Support Ongoing Strong Growth of Pre-Filled Drug Delivery Business". Madrid....
- [6] MedinCell S.A.. (2/11/21). "Press Release: Tremendous Success for MedinCell’s €30 Million Capital Increase for Qualified Investors". Montpellier....
- [7] MedinCell S.A.. (6/16/20). "Press Release: MedinCell Announces the Great Success of Its Capital Increase and Raises 15.6 M€ [Not for publication nor to distribution in the United States, Canada, Japan or Australia]". Montpellier....
- [8] MedinCell S.A.. (5/27/20). "Press Release: MedinCell Secures €10.9 Million Non-Dilutive Financing". Montpellier....
- [9] MedinCell S.A.. (11/28/19). "Press Release: MedinCell Receives $19 Million Grant for Its mdc-WWM Program". Montpellier....
- [10] MorphoSys AG. (2/27/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received U.S. FDA Approval for Tremfya One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis". Planegg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top